Handelsavisen
prelaunch
Companies Healthcare 1788.TWO
17
1788.TWO TPEx Medical Equipment, Supplies & Distribution

Hi-Clearance Inc

$135,50
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
5,15 %
Op margin
9,9 %
ROE
12,1 %
Net margin
8,6 %
Debt / equity
0,34
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Hi-Clearance Inc provides medical equipment, supplies, and distribution services within the healthcare sector.

Business. Hi-Clearance Inc (1788.TWO) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm is listed on the Taiwan Premium Board (TPEx) and engages in the sale of medical products. Specific details regarding operating segments, headquarters location, and geographic revenue mix are not available in the provided data.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
ActivityHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
12,1 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 1788.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 1788.TWO. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Hi-Clearance Inc (1788.TWO) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm is listed on the Taiwan Premium Board (TPEx) and engages in the sale of medical products. Specific details regarding operating segments, headquarters location, and geographic revenue mix are not available in the provided data.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryMedical Equipment, Supplies & Distribution
    ActivityHealthcare Services & Equipment
    AI synthesis
    GENERATED

    Hi-Clearance Inc maintains a conservative capital structure with a debt-to-equity ratio of 0.34, well below the industry median of 0.65, indicating a strong equity position relative to its liabilities. The company's liquidity position is characterized as medium, with a current ratio of 1.72, suggesting it can cover its short-term obligations but with limited excess capacity. Free cash flow of TWD 116.24 million supports operational flexibility, though cash and equivalents of TWD 89.56 million are modest relative to total liabilities.

    Profitability metrics show a return on equity (ROE) of 12.08% and a return on assets (ROA) of 7.25%, both exceeding the industry median of 9.5% and 5.8%, respectively. This suggests Hi-Clearance Inc is generating returns above the industry average, driven by strong gross and operating margins. The company's operating income of TWD 422.16 million and net income of TWD 368.51 million reflect efficient cost management and pricing power in its core markets.

    The company's revenue is concentrated in a single disclosed segment, with no geographic breakdown provided in the latest financials. This lack of diversification may expose the company to regional or sector-specific risks, though the healthcare services and equipment industry is generally stable and less cyclical.

    Looking ahead, the company is projected to maintain a steady growth trajectory, with revenue expected to increase by 4.2% in the current fiscal year and 3.8% in the following year. This growth is supported by a consistent capital expenditure strategy, with CAPEX of TWD -139.84 million in the latest period, indicating a focus on cost control and asset optimization.

    Risk factors include a liquidity risk due to negative net cash after subtracting total debt, which could limit the company's ability to respond to unexpected capital needs. The dilution risk is assessed as low, with no significant dilution sources identified in the latest filings. However, the company's reliance on a single business segment and limited geographic diversification could pose operational and market concentration risks.

    Recent events include the filing of the latest financial report, which disclosed strong operating cash flow of TWD 389.54 million and a net income margin of 8.61%. No major regulatory or legal issues were reported in the latest filings, and the company has not issued any new shares in the past 12 months.

    Key takeaways
    • Hi-Clearance Inc maintains a conservative capital structure with a debt-to-equity ratio of 0.34, below the industry median.
    • The company's ROE of 12.08% and ROA of 7.25% indicate strong profitability relative to industry peers.
    • Revenue is concentrated in a single business segment, with no geographic diversification disclosed.
    • The company is projected to grow revenue by 4.2% in the current fiscal year and 3.8% in the following year.
    • Liquidity risk is present due to negative net cash after subtracting total debt, but dilution risk is assessed as low.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $135,50
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $3.05B
    Net cash
    -$958.7M
    Current ratio
    1.7
    Debt / equity
    0.3
    ROA
    7.2%
    ROE
    12.1%
    Cash conversion
    106.0%
    CapEx / revenue
    -3.3%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin9,9 %Above median
    Net Margin8,6 %Above median
    ROE12,1 %Above P75
    Capex / Rev-3,3 %Above median
    D/E0,34Below median
    Cash Conv1,06Above median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • Hi-Clearance Inc Market data — financials · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    1788.TWOCanonical
    TPEx · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage